Potential of calcitonin gene-related peptide in coronary heart disease

Pharmacology

Volumn 60, Issue 1, 2000, Pages 1-8

  Franco Cereceda, Anders ^a   Liska, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angina pectoris; C fibre afferents; Calcitonin gene related peptide; Capsaicin; Cardiac ischaemia; Coronary arteries; Heart; Vasodilation

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROKININ A; SUBSTANCE P;

ANGINA PECTORIS; CHRONOTROPISM; CORONARY ARTERY DILATATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; INOTROPISM; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033971268     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028339     Document Type: Review

References (49)

1. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG: Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide.Science 1985;229:1094-1097.
2. Gulbenkian S, Merighi A, Wharton J, Varndell IM, Polak JM: Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in secretory vesicles of peripheral nerves in the guinea pig. J Neurocytol 1986;15:535-542.
3. Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, Fukase M, Noda T, Fujita T: Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 1989;256:E331-E335.
4. Gardiner SM, Compton AM, Kemp PA, Bennett T, Bose C, Foulkes R, Hughes B: Antagonistic effect of human alpha-CGRP(8-37) on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Com 1990;171:938-943.
5. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y: A cDNA encoding the calcitonin gene-related peptide type I receptor. J Biol Chem 1996;271:11325-11329.
6. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C: Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 1985;58: 213-217.
7. + channels. Nature 1990;344:770-773.
8. Gray DW, Marshall I: Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 1992;107:691-696.
9. Franco-Cereceda A, Henke H, Lundberg JM, Petermann JB, Hökfelt T, Fischer JA: Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunorcactive sensory neurons in animals and man: Distribution and release by capsaicin. Peptides 1987;8:399-410.
10. Franco-Cereceda A: Calcitonin gene-related peptide and human epicardial coronary arteries: Presence, release and vasodilator effects. Br J Pharmacol 1991;102:506-510.
11. Holzer P: Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurones. Pharmacol Rev 1991;43:143-201.
12. Szolcsanyi J: Capsaicin-sensitive chemoceptive neural system with dual sensory-efferent function; in Chal LA, Szolcsanyi J, Lembeck F (eds): Antidromic Vasodilation and Neurogenic Inflammation. Budapest, Akademiai Kiado. 1984, pp 27-55.
13. Preibisz JJ: Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis. Am J Hypertens 1993;6:434-450.
14. Katayama M, Nadel JA, Bunnett NW, Di Maria GU, Haxhiu M, Borson DB: Catabolism of Calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 1991;12: 563-567.
15. Franco-Cereceda A: Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone. Acta Physiol Scand 1988; 133(suppl 569): 1-63.
16. Liu L, Simon SA: A rapid capsaicin-activated current in rat trigeminal ganglion neurons. Proc Natl Acad Sci USA 1994;91:738-741.
17. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
18. Ichihara K, Abiko Y: Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart. J Pharmacol Exp Ther 1982;222: 720-725.
19. Geppetti P, Del Bianco E, Tramontana M, Vigano T, Folco GC, Maggi CA, Manzini S, Fanciullacci M: Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart. J Pharmacol Exp Ther 1991;259:759-765.
20. Longhurst JC, Dittman LE: Hypoxia, bradykinin. and prostaglandins stimulate ischemically sensitive visceral afferents. Am J Physiol 1987; 253:H556-H567.
21. Uchida Y, Murao S: Acid-induced excitation of afferent cardiac sympathetic nerve fibres. Am J Physiol 1975;228:27-33.
22. + derived from lactic acid and hypercapnia. Am J Physiol 1992;262:H748-H753.
23. Franco-Cereceda A: Resiniferatoxin-, capsaicin-, and CGRP-evoked porcine coronary vasodilation is independent of EDRF mechanisms but antagonized by CGRP(8-37). Acta Physiol Scand 1991;143:331-337.
24. Edvinsson L, Jansen Olesen I, Kingman TA, McCulloch J, Uddman R: Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: Possible involvement of CGRP. Cephalalgia 1995; 15:373-383.
25. Rinder J, Lundberg JM: Effects of hCGRP 8-37 and the NK1-receptor antagonist SR 140,333 on capsaicin-evoked vasodilation in the pig nasal mucosa in vivo. Acta Physiol Scand 1996; 156:115-122.
26. Hong KW, Yu SS, Shin YW, Kim CD, Rhim BY, Lee WS: Decreased CGRP level with increased sensitivity to CGRP in the pial arteries of spontaneously hypertensive rats. Life Sci 1997;60:697-705.
27. Yaoita H, Sato E, Kawaguchi M, Saito T, Machara K, Maruyama Y: Nonadrenergic noncholinergic nerves regulate basal coronary flow via release of capsaicin-sensitive neuropeptides in the rat heart. Circ Res 1994;75:780-788.
28. Sekiguchi N, Kanatsuka H, Sato K, Wang Y, Akai K, Komaru T, Takishima T: Effect of calcitonin gene-related peptide on coronary microvessels and its role in acute myocardial ischemia. Circulation 1994;89:366-374.
29. Gennari C, Fischer JA: Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int 1985;37:581-584.
30. McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, MacIntyre I, Maseri A: Calcitonin gene-related peptide: A potent dilator of human epicardial coronary arteries. Circulation 1986;74:1243-1247.
31. Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC: Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens 1992;10:1227-1234.
32. Ferrari R, Panzali AF, Poole-Wilson PA, Anand IS: Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure. Lancet 1991;338:1084.
33. Shekhar YC, Anand IS, Sarma R, Ferrari R, Wahi PL, Poole-Wilson PA: Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure. Am J Cardiol 1991;67:732-736.
34. Gennari C, Nami R, Agnusdei D, Fischer JA: Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. Cardiovasc Res 1990; 24:239-241.
35. Mair J, Lechleitner P, Langle T, Wiedermann C, Dienstl F, Saria A: Plasma TGRP in acute myocardial infarction. Lancet 1990;335:168.
36. Edvinsson L, Ekman R, Thulin T: Reduced levels of CGRP hut not substance P during and after treatment of severe hypertension in man. J Hum Hypertens 1989;3:267-270.
37. Kawasaki H, Saito A, Takasaki K: Age-related decrease of CGRP-containing vasodilator innervation in mesenteric resistance vessel of spontaneously hypertensive rat. Circ Res 1990; 67:733-743.
38. Terazawa E, Shimonaka H, Oohata H, Ueda N, Ishizawa Y, Akamatsu S, Dohi S: Calcitonin gene-related peptide and human atrial natriuretic hormone levels in response to cardiac operation under high dose fentanyl anesthesia. Masui 1995;44:1202-1207.
39. Källner G, Öwall A, Franco-Cereceda A: Myocardial outflow of calcitonin gene-related peptide in relation to metabolic stress during coronary bypass grafting without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;117: 447-453.
40. Lüscher TF, Barton M: Biology of the endothelium. Clin Cardiol 1997;20:3-10.
41. Ludman PF, Maseri A, Clark P, Davies GJ: Effects of calcitonin gene-related peptide on normal and atheromatous vessels and on resistance vessels in the coronary circulation in humans. Circulation 1991;84:1993-2000.
42. Uren NG, Seydoux C, Davies GJ: Effect of calcitonin gene-related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc Res 1993;27:1477-1481.
43. Li Y-J, Xiao Z-S, Peng C-F, Deng H-W: Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol 1996;311:163-167.
44. Lu E-X, Peng C-F, Li Y-J, Cheng S-X: Calcitonin gene-related peptide-induced preconditioning improves preservation with cardioplegia. Ann Thorac Surg 1996;62:1748-1751.
45. Nuki C, Kawasaki H, Takasaki K, Wada A: Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels. J Pharmacol Exp Ther 1994;268:59-64.
46. Källner G, Franco-Cereceda A: Aggravation of myocardial infarction in the porcine heart by capsaicin-induced depiction of calcitonin gene-related peptide. J Cardiovasc Pharmacol 1998; 32:500-504.
47. Bell D, McDermott BJ: Calcitonin gene-related peptide in the cardiovascular system: Characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 1996;48:253-288.
48. Hearse DJ: Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection? Cardiovasc Res 1995;30:1-17.
49. Yamada M, Ishikawa T, Fujimoro A, Goto K: Local neurogenic regulation of rat hindlimb circulation: Role of calcitonin gene-related peptide in vasodilatation after skeletal muscle contraction. Br J Pharmacol 1997;122:703-709.